Aug 2026· Neurobiology of Disease· pp.
107574
· 0 citations· 72 references
Medicine
TL;DR
RNA-seq data from ALS patients confirmed significant alterations in the expression of host genes of ALS-related circRNAs and hub proteins in ALS-affected CNS tissues, and these findings identify circRNAs as potential key contributors to ALS pathogenesis.
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive loss of motor neurons, with most cases lacking a clear genetic basis. Emerging evidence highlights the involvement of non-coding RNAs, particularly circular RNAs (circRNAs), in disease onset and progression. Here, we investigated circRNAs implicated in ALS and related motor neuron diseases (MNDs). Here we provide a general overview of circular RNA metabolism and cellular functions. We then present our systematic literature review that identified ALS-associated circRNAs, followed by in silico analyses of 15 circular RNA candidates that were selected based on most compelling data regarding ALS. Our results revealed that several circular RNAs regulate ALS-related genes, such as unfolded protein response, oxidative stress, cell cycle regulation, and apoptosis. Protein-RNA interaction analysis further showed that ALS-related circRNAs can sponge 20 RNA-binding proteins. Additionally, molecular docking analysis demonstrated that ALS-associated FUS variants significantly alter its binding affinity to circular RNAs. RNA-seq data from ALS patients confirmed significant alterations in the expression of host genes of ALS-related circRNAs and hub proteins in ALS-affected CNS tissues. Collectively, our findings identify circRNAs as potential key contributors to ALS pathogenesis.
A narrative review synthesizes findings from key microarray studies, focusing on dysregulated pathways such as ribosomal function, protein synthesis, and metabolic processes within motor nerves and Schwann cells, and the emerging role of competitive endogenous RNA (ceRNA) networks.
F. Jorge· Brazilian Journal of Biology· 0 citations
This work identifies transcriptional pathways linking variants in definitive ALS genes to widespread coordinated co-expression activity driven by gene-specific transcriptional programs, and establishes a generalizable framework that is readily applicable across heritable diseases for the identification of disease-relev...
M. Fiorini, A. Dilliott, S. Alsabagh et al.· medRxiv· 0 citations
The results highlight that circRNAs-associated networks exhibit lesion-specific expression and structural diversity in SPMS and may participate in MS-associated biological processes.
Current evidence on the RNA regulatory networks in PD is examined, highlighting the role of transcript isoforms and RBPs in neuronal dysfunction and emerging data suggest that dysregulation of RNA binding proteins (RBPs) may influence RNA processing in PD.
Maria Giusy Bruno, G. Menichetti, Angela Valentino et al.· Genes· 0 citations
Key biological mechanisms underlying TDP-43 pathology, emerging therapeutic strategies, and evolving approaches to clinical trial design and biomarker development are examined.
C. Estévez-Fraga, R. Álvarez-Velasco, T. Afroz et al.· Journal of Neurology· 1 citation
This study analyses publicly available human single-nucleus RNA sequencing from four disorders using donors as the unit of inference throughout, finding down-regulated autosomal lncRNAs from Alzheimer's disease and multiple sclerosis are disorder-specific rather than pan-neuroinflammatory.
Hidenori Tani· Brain Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.